Clinical Trials Logo

Pneumonitis clinical trials

View clinical trials related to Pneumonitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04721444 Completed - Lung Cancer Clinical Trials

Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)

OCTAPUS-AI
Start date: January 27, 2021
Phase:
Study type: Observational

Distinguishing changes on patients that have received thoracic radiotherapy and patients that are currently receiving or have recently received IO and presenting lung changes which will be identified using AI.

NCT ID: NCT04302688 Completed - Pneumonitis Clinical Trials

Accurate Classification System for Patients With COVID-19 Pneumonitis

Start date: December 10, 2019
Phase:
Study type: Observational

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

NCT ID: NCT03730428 Completed - Pneumonitis Clinical Trials

Everolimus Related Pneumonitis in MBC

Start date: July 15, 2017
Phase:
Study type: Observational

To study the drug-related pneumonitis during mTOR inhibitor therapy in patients with metastatic breast cancer.

NCT ID: NCT03012958 Completed - Dyspnea Clinical Trials

Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease

LCI
Start date: July 2014
Phase:
Study type: Observational

The purpose of this study is to learn more about new noninvasive ways of detecting lung disease in US Military personnel and people who worked as contractors during military operations in Iraq and Afghanistan. This study is looking at conducting a type of breathing test called the lung clearance index (LCI) test which is being investigated as a potential noninvasive way to detect the type of lung disease that may be seen in symptomatic deployers retuning from Iraq and Afghanistan.

NCT ID: NCT02788643 Completed - Lung Cancer Clinical Trials

Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies

BRONCOLL
Start date: May 2014
Phase:
Study type: Observational

Collagens are proteins present in all tissues. Besides their structural role, recent data showed that they were able to regulate many cellular functions. Many interactions occur between extracellular matrix macromolecules, especially collagen, and various cell types. These interactions can be controlled by peptides derived extracellular matrix macromolecules, called matrikines. Previous work from the investigators laboratory and others have shown that several C-terminal domain (NC1 domains) from basement membrane-associated collagens could regulate many cellular activities. Lung is an organ particularly abundant in basement membranes. It is likely that various lung diseases may affect metabolism of basement membrane associated collagens. To the investigators knowledge, no study has focused on the expression of collagen XIX α1 chain and collagen IV chains α3 and α4 chains in lung and studied possible variations of expression in various pathophysiological situations. The aim of this study are to: - Study the presence of collagen IV and XIX (or fragments) in different types of sampling such as bronchoalveolar lavage, pulmonary aspiration and bronchial biopsies - Evaluate quantitative variations of expression of these collagen in different pulmonary diseases, especially chronic obstructive bronchopneumopathy, infectious pneumonia, pneumonitis or lung cancer.

NCT ID: NCT02246361 Completed - Diverticulitis Clinical Trials

Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication

EDIFIP
Start date: September 2014
Phase: Phase 4
Study type: Interventional

The purpose of this "before-after" prospective multicenter study is to assess the impact of six Patient Information Leaflets (PILs) on Doctor Patient Communication scale (DPC) and adherence scale for common acute illnesses in emergency ward.

NCT ID: NCT00997555 Completed - Pneumonia Clinical Trials

Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients

Start date: October 2009
Phase: N/A
Study type: Interventional

The investigators hypothesize that the scheduled use of bronchoscopy on a regular basis after inhalation injury in burn patients will improve outcome by providing pulmonary hygiene, decrease the incidence of pneumonia, and detect pneumonia earlier than standard treatment without bronchoscopy.

NCT ID: NCT00081315 Completed - Clinical trials for Non-Small Cell Lung Carcinoma

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Start date: November 2003
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the activity of subcutaneous (SC) amifostine on the incidence and severity of acute radiochemotherapy-induced esophagitis in patients with unresectable Stage IIIA or IIIB non-small cell lung cancer (NSCLC) receiving combined modality therapy.